PATENT CLAIM ANALYSIS

Application Number: 15911832
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "171000"]

Abstract:
The invention relates to doxepin, pharmaceutically acceptable salts and prodrugs of doxepin; compositions containing the same, and the use of any of the aforementioned for the treatment of sleep disorders.

Claim (Index 24):
The composition of  claim 23 , wherein the at least one additional sleep medication is selected from a 5-HT2 antagonist, ketanserin, a H3 agonist, an orexin antagonist, a noradrenergic antagonist, a galanin agonist, a CRH antagonist, Gaboxadol, other GABA-A direct antagonists, a GABA reuptake inhibitor, tiagabine, a growth hormone, a growth hormone agonist, estrogen, an estrogen agonist, or a melatonin agonist.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.36
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14045645', '15357171', '15289288', '13692715', '15797195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.787722187119415
- 35 USC 102 Novelty (BERT): 0.5798552181498411
- Combined Prediction Score: 0.7669354902224575
- Mean Citation Score: 373.914892
- Max Citation Score: 439.11426
- Similarity Product: 231.59499263476607

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test